ADMA Biologics ADMA Issuance of warrants to purchase common stock
Issuance of warrants to purchase common stock at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's issuance of warrants to purchase common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's issuance of warrants to purchase common stock?
- ADMA Biologics (ADMA) reported issuance of warrants to purchase common stock of $1.4M in Q4 2023.
- What does issuance of warrants to purchase common stock mean?
- This reflects the accounting value assigned to warrants issued to purchase common stock, typically as part of financing arrangements or incentive packages. It measures the potential future dilution and the capital structure impact of derivative equity instruments.